Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Transplantation of IPSC-Derived Cardiomyocyte Patches for Ischemic Cardiomyopathy

View ORCID ProfileShigeru Miyagawa, Satoshi Kainuma, Takuji Kawamura, Kota Suzuki, Yoshito Ito, Hiroko Iseoka, Emiko Ito, Maki Takeda, Masao Sasai, Noriko Mochizuki-Oda, Tomomi Shimamoto, Yukako Nitta, Hiromi Dohi, Tadashi Watabe, Yasushi Sakata, Koichi Toda, View ORCID ProfileYoshiki Sawa
doi: https://doi.org/10.1101/2021.12.27.21268295
Shigeru Miyagawa
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shigeru Miyagawa
  • For correspondence: miya-p@surg1.med.osaka-u.ac.jp
Satoshi Kainuma
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takuji Kawamura
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kota Suzuki
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshito Ito
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroko Iseoka
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emiko Ito
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maki Takeda
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masao Sasai
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriko Mochizuki-Oda
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomomi Shimamoto
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukako Nitta
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiromi Dohi
2Center for iPS Cell Research and Application, Kyoto University, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Watabe
3Department of Nuclear Medicine and Tracer Kinetics, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasushi Sakata
4Department of Cardiology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koichi Toda
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiki Sawa
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yoshiki Sawa
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Despite major therapeutic advances, heart failure remains a life-threatening disorder, with 26 million patients worldwide, causing more deaths than cancer as a non-communicable disease. Therefore, novel strategies for the treatment of heart failure continue to be an important clinical need. Based on preclinical studies, allogenic human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) patches have been proposed as a potential therapeutic candidate for heart failure. We report the implantation of allogeneic hiPSC-CM patches in a patient with ischemic cardiomyopathy (ClinicalTrials.gov, #jRCT2053190081).

Methods The patches were produced under clinical-grade conditions and displayed cardiogenic phenotypes and safety in vivo (severe immunodeficient mice) without any genetic mutations in cancer-related genes. The patches were then implanted via thoracotomy into the left ventricle epicardium of the patient under immunosuppressive agents.

Results Positron emission tomography and computed tomography confirmed the possible efficacy and did not detect tumorigenesis in either the heart or other organs; the clinical symptoms improved 6 months after surgery, without any major adverse events, suggesting that the patches were well-tolerated. Furthermore, changes in the wall motion in the transplanted site were recovered, suggesting a favorable prognosis and the potential tolerance to exercise.

Conclusions This study is the first report of a successful transplant of hiPSC-CMs for severe ischemic cardiomyopathy.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Trial ID: jRCT2053190081

Funding Statement

This study was funded by Japan Agency for Medical Research and Development (AMED) under the Grant Numbers JP20bm0204003, JP17bk0104044, 19bk0104002, and JP20bk0104110.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The regenerative treatment protocol (Japan Registry of Clinical Trials, https://jrct.niph.go.jp/en-latest-detail/jRCT2053190081) using allogeneic iPSC-CM patches was approved by the institutional review boards of Osaka University (#199006-A) and the Ministry of Health, Labor, and Welfare, Japan (#2019-143).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Subject codes: Cell Therapy, Stem Cells, Translational Studies, Heart Failure, Myocardial Infarction

Data Availability

All data produced in the present study are available upon reasonable request to the authors

  • Non-standard Abbreviations and Acronyms

    4DCT
    four-dimensional computed tomography
    CGH
    comparative genomic hybridization
    CiRA
    Center for iPS Cell Research and Application, Kyoto University
    CNV
    copy number variation
    Cx
    circumflex coronary artery
    cTNT
    cardiac Troponin T
    ESS
    end-systolic wall stress
    FDG-PET
    fluorodeoxyglucose-positron emission tomography
    FWHM
    full-width at half-maximum
    HBSS(+)
    Hanks’ Balanced Salt Solution
    H&E
    hematoxylin and eosin
    hiPSC-CM
    human induced pluripotent stem cell-derived cardiomyocyte
    IABP
    intra-aortic balloon pumping
    LAD
    left anterior descending coronary artery
    LV
    left ventricle
    LVESVI
    left ventricle end-systolic volume index
    MBF
    myocardial blood flow
    MCB
    master cell bank
    MI
    myocardial infarction
    NOG
    NOD/Shi-scid, IL-2R γnull
    NYHA
    New York Heart Association classification
    PCI
    percutaneous coronary intervention
    peak VO2
    peak oxygen uptake
    PET
    positron emission tomography
    RCA
    right coronary artery
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted January 02, 2022.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Transplantation of IPSC-Derived Cardiomyocyte Patches for Ischemic Cardiomyopathy
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Transplantation of IPSC-Derived Cardiomyocyte Patches for Ischemic Cardiomyopathy
    Shigeru Miyagawa, Satoshi Kainuma, Takuji Kawamura, Kota Suzuki, Yoshito Ito, Hiroko Iseoka, Emiko Ito, Maki Takeda, Masao Sasai, Noriko Mochizuki-Oda, Tomomi Shimamoto, Yukako Nitta, Hiromi Dohi, Tadashi Watabe, Yasushi Sakata, Koichi Toda, Yoshiki Sawa
    medRxiv 2021.12.27.21268295; doi: https://doi.org/10.1101/2021.12.27.21268295
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Transplantation of IPSC-Derived Cardiomyocyte Patches for Ischemic Cardiomyopathy
    Shigeru Miyagawa, Satoshi Kainuma, Takuji Kawamura, Kota Suzuki, Yoshito Ito, Hiroko Iseoka, Emiko Ito, Maki Takeda, Masao Sasai, Noriko Mochizuki-Oda, Tomomi Shimamoto, Yukako Nitta, Hiromi Dohi, Tadashi Watabe, Yasushi Sakata, Koichi Toda, Yoshiki Sawa
    medRxiv 2021.12.27.21268295; doi: https://doi.org/10.1101/2021.12.27.21268295

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Cardiovascular Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (179)
    • Allergy and Immunology (434)
    • Anesthesia (99)
    • Cardiovascular Medicine (948)
    • Dentistry and Oral Medicine (178)
    • Dermatology (110)
    • Emergency Medicine (260)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
    • Epidemiology (8987)
    • Forensic Medicine (4)
    • Gastroenterology (420)
    • Genetic and Genomic Medicine (1959)
    • Geriatric Medicine (190)
    • Health Economics (402)
    • Health Informatics (1329)
    • Health Policy (660)
    • Health Systems and Quality Improvement (519)
    • Hematology (212)
    • HIV/AIDS (420)
    • Infectious Diseases (except HIV/AIDS) (10809)
    • Intensive Care and Critical Care Medicine (575)
    • Medical Education (200)
    • Medical Ethics (54)
    • Nephrology (222)
    • Neurology (1830)
    • Nursing (110)
    • Nutrition (274)
    • Obstetrics and Gynecology (353)
    • Occupational and Environmental Health (470)
    • Oncology (999)
    • Ophthalmology (298)
    • Orthopedics (111)
    • Otolaryngology (182)
    • Pain Medicine (126)
    • Palliative Medicine (44)
    • Pathology (265)
    • Pediatrics (580)
    • Pharmacology and Therapeutics (276)
    • Primary Care Research (234)
    • Psychiatry and Clinical Psychology (1903)
    • Public and Global Health (4123)
    • Radiology and Imaging (676)
    • Rehabilitation Medicine and Physical Therapy (368)
    • Respiratory Medicine (549)
    • Rheumatology (225)
    • Sexual and Reproductive Health (191)
    • Sports Medicine (177)
    • Surgery (207)
    • Toxicology (39)
    • Transplantation (109)
    • Urology (81)